Dual antiplatelet therapy after drug-eluting stent implantation: when is "enough" enough?

J Cardiovasc Pharmacol. 2014 Jul;64(1):38-40. doi: 10.1097/FJC.0000000000000108.

Authors

Enrico Cerrato¹, Fabrizio DʼAscenzo, Giuseppe G Biondi-Zoccai, Antonio Abbate

Affiliation

¹ *Division of Cardiology, Department of Internal Medicine, University of Turin, Turin, Italy; †Interventional Cardiology Unit, Hospital Clinico San Carlos, Madrid, Spain; ‡Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy; and §Virginia Commonwealth University, Pauley Heart Center, Medical College of Virginia Campus, Richmond, VA.

PMID: 24736637
DOI: 10.1097/FJC.0000000000000108

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Drug Therapy, Combination
Drug-Eluting Stents*
Humans
Percutaneous Coronary Intervention / methods*
Platelet Aggregation Inhibitors / administration & dosage
Platelet Aggregation Inhibitors / therapeutic use*
Time Factors

Substances

Platelet Aggregation Inhibitors